AzTrials
AzTrials

Care TransitionNCT07661355

Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers

A study testing Patient-Centered Program and Family Caregiver Enhanced Program in people with Care Transition, run by Wake Forest University Health Sciences at 4 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study investigates better ways to help people after they leave the hospital and how to involve their families in this process. The main goal is to see if adding family support to a patient-centered hospital-to-home intervention helps patients stay safely at home, spend fewer days back in the emergency room or… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Care Transition
What is being tested?
Patient-Centered Program and Family Caregiver Enhanced Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,560 participants
Where
4 sitesUnited States
Study dates
22 Jul 2026to Nov 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Patient Inclusion Criteria:

  • 65 and older
  • English and Spanish speaking
  • Preadmission location: community dwelling
  • Distance from Hospital: Local and Distant (rural) included
  • Cognitive impairment, dementia allowed
  • Technology Literacy: Flexible from high to low
  • EPIC readmission risk score over 12
  • Discharged home

Patient Exclusion Criteria:

  • Admitted from skilled nursing facility
  • Discharged to skilled nursing facility
  • Left Against Medical Advice (AMA)
  • Planned readmission
  • Died during index admission
  • Caregiver unwilling to participate
  • Admitted to surgical services

Caregiver Inclusion Criteria:

  • Adults 18 and older
  • English and Spanish speaking
  • Providing tangible support to patient
  • Distance from Hospital: Local and Distant (rural) included
  • Only Mild Cognitive Impairment allowed
  • Able to be trained in Video Visit Technology
  • Available to support post-discharge

Caregiver Exclusion Criteria:

  • Has a greater than a mild cognitive impairment (< 12 on MoCA)

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States4 sites, 4 recruiting
  • Davie Medical Center

    Bermuda Run, North Carolina, 27006

    Houston, 508-688-4341, Thomas.Houston@advocatehealth.org

    Recruiting
  • High Point Medical Center

    High Point, North Carolina, 27262

    Houston, 508-688-4341, Thomas.Houston@advocatehealth.org

    Recruiting
  • Atrium Health Wake Forest Baptist Wilkes Medical Center

    North Wilkesboro, North Carolina, 28659

    Houston, 508-688-4341, Thomas.Houston@advocatehealth.org

    Recruiting
  • Atrium Health Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina, 27157

    Houston, 508-688-4341, Thomas.Houston@advocatehealth.org

    Recruiting

Other trials in United States

About this study

This study investigates better ways to help people after they leave the hospital and how to involve their families in this process. The main goal is to see if adding family support to a patient-centered hospital-to-home intervention helps patients stay safely at home, spend fewer days back in the emergency room or going back into the hospital. The study team also wants to see if the family-centered approach helps improve the patient's ability to do everyday activities without feeling overwhelmed. Two approaches are being compared: one focuses just on the patient, and the other includes special strategies to better support families involved too. Family will be involved in assessing what the patient and family needs. The family-focused approach not only emphasizes the experience, health, and safety of the patient but also the experience of the family member caring for the older adult. The study also involves families in education and provides families skills-building experiences that can help with caregiving stress, problem-solving, and communicating with the healthcare team. The approach will help the family member prepare for their loved one's transition home and provide coaching with the goal of reducing the mental, physical and financial burden of providing care at home. To spread the intervention across many states, the study team will be using telephone calls, video calls, and other technologies as families prefer.

Read the detailed description

For all patients, the transition from hospital to home is a vulnerable period, placing them at great risk for adverse events. In a landmark 2003 report on care transitions, investigators found that 19% of patients experience adverse events soon after discharge (many preventable or ameliorable) and 66% experience adverse drug events. Care transitions also impact those around the recently discharged patient - increasing the burden on family members who provide caregiving support. Without communication and engagement in care transitions, family members experience reduced preparedness for their post-discharge caregiving role, increased caregiver burden, social isolation, and reduced mental/physical well-being.

Patient-centered care transitions can be supported through evidence-based interventions. Recent knowledge generated through PCORI's Transitional Care Evidence to Action Network and other research programs has identified remaining evidence gaps. This Phased Large Award for Comparative Effectiveness Research entitled Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers will create new knowledge related to engaging and supporting family caregivers. After optimization in the feasibility phase, briefly, the Phase 2 comparative effectiveness trial will have the following characteristics:

Setting: 20 Acute Care Hospitals across 5 states selected for rural/urban diversity and patient characteristics Sample: Dyads: Older Adults (N = 1,200) discharged to home and their Family Caregivers (N = 1,200)

Comparators:

Comparator A is an active care transition program that includes effective strategies focused on the patient.

Comparator B includes all Comparator A active strategies, plus focused family caregiver engagement and support.

Randomization:

1:1 Dyad-level RCT stratified by rural/urban home setting and presence of patient cognitive impairment

Patient-Centered Outcomes Include: Patient remaining safely at home (60-day hospital free days), post-discharge adverse events, patient-reported outcomes (e.g.: role functioning). Also, this study extends beyond prior effectiveness research by assessing family-caregiver-reported outcomes (e.g.: caregiver burden).

Conditions
Care Transition
Being tested
Patient-Centered Program, Family Caregiver Enhanced Program
Keywords
hospitalization, older adults, aging, care transition, mild cognitive impairment
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient-Centered ProgramOther

    Effective strategies focused on the patient such as patient needs assessment, multi-disciplinary discharge planning, discharge instructions, follow-up education, and follow-up assessments.

  • Family Caregiver Enhanced ProgramOther

    Caregiver strategies such as a family caregiver needs assessment, structured education, and skill building.

Study groups in NCT07661355
Study groupRoleWhat they receive
Patient Focused StrategiesActive comparatorAn active care transition program that includes effective strategies focused on the patient.
Receives: Other: Patient-Centered Program
Patient and Family Focused StrategiesExperimentalAn active care transition program that includes effective strategies focused on the patient plus focused family caregiver engagement and support.
Receives: Other: Patient-Centered Program; Other: Family Caregiver Enhanced Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hospital-Free Days

    The count of days alive and outside acute care hospitals from discharge to day 60. It will be calculated using EHR and Medicare claims data to objectively capture hospital free days elements (i.e.: mortality days, inpatient days, observation stays, and ED visits).

    Measured: Day 60

Secondary outcomes (19)
  1. Number of Hospital-Free Days

    The count of days alive and outside acute care hospitals from discharge to a specified day. It will be calculated using EHR and Medicare claims data to objectively capture hospital free days elements (i.e.: mortality days, inpatient days, observation stays, and ED visits).

    Measured: Day 30, 90, and 180

  2. Number of Patient Readmissions

    All-cause, acute care readmissions calculated as both a count and dichotomous using EHR and Medicare claims data.

    Measured: Day 30, 60, and 90

  3. Zarit Burden Interview Score

    Caregiver burden will be measured using the 12-item Zarit Burden Interview. Scores will range from 0 to 48. Higher scores indicate greater burden.

    Measured: Day 60

  4. Zarit Burden Interview Score

    Caregiver burden will be measured using the 12-item Zarit Burden Interview. Scores will range from 0 to 48. Higher scores indicate greater burden.

    Measured: Day 30, 90, and 180

  5. PROMIS Ability to Participate in Social Roles and Activities 8-item short form (APS-SF8) Score

    Social role function is one's ability to perform usual social roles and activities (e.g.: leisure, family). It will be measured by using the APS-SF8. Each item is scored using a 5-point Likert scale (1=Never, 5=Always). Scores are typically converted to a standardized T-score, with a mean of 50 and a standard deviation of 10.

    Measured: Day 60

  6. PROMIS Ability to Participate in Social Roles and Activities 8-item short form (APS-SF8) Score

    Social role function is one's ability to perform usual social roles and activities (e.g.: leisure, family). It will be measured by using the APS-SF8. Each item is scored using a 5-point Likert scale (1=Never, 5=Always). Scores are typically converted to a standardized T-score, with a mean of 50 and a standard deviation of 10.

    Measured: Day 30, 90 and 180

  7. Partners at Care Transitions Measure (PACT-M) - Patient Satisfaction Score

    Patient satisfaction will be measured using the 9-item PACT-M-1. Scores will range from 9 to 45. Higher scores indicate better perception of the quality of discharge arrangements.

    Measured: Day 7

  8. Partners at Care Transitions Measure (PACT-M) - Patient Self-Efficacy Score

    Patient self-efficacy will be measured using the 8-item PACT-M-2. Scores will range from 8 to 40. Higher scores indicate a better experience with managing care at home.

    Measured: Day 30

  9. Patient Activation Measures Score

    Patient activation will be measured using the 13-item Patient Activation Measures. Scores will range from 0 to 100. Higher scores indicate greater knowledge, skills, and confidence for managing their health and health care.

    Measured: Day 60

  10. Preparedness for Caregiving Scale Score

    Family caregiver preparedness will be measured using the 8-item Preparedness for Caregiving Scale. Scores will range from 0 to 32. Higher scores indicate better preparedness for the caregiving role.

    Measured: Day 7

  11. Caregiver Self-Efficacy Scale Score

    Family caregiver self-efficacy will be measured using the 8-item Caregiver Self-Efficacy Scale. Scores will range from 8 to 80. Higher scores indicate higher self-efficacy.

    Measured: Day 30

  12. Caregiver Activation Measures Score

    Patient activation will be measured using the 13-item Caregiver Activation Measures. Scores will range from 0 to 100. Higher scores indicate greater knowledge, skills, and confidence for managing their health and health care.

    Measured: Day 60

  13. Visit Completion Rate

    Number of patients that completed follow-up visit

    Measured: Day 14 and 30

  14. Time to First Outpatient Follow-up

    Number of days between discharge and first outpatient follow-up visit

    Measured: Day 14 and 30

  15. Rate of Access to Community Services - Patient

    Number of patients that had screening and intervention assessment for unmet social needs.

    Measured: Day 30 and 60

  16. Rate of Access to Community Services - Caregiver

    Number of caregivers that had screening and intervention assessment for unmet social needs

    Measured: Day 30 and 60

  17. Partners at Care Transitions Measures - Adverse Events Score

    Adverse events will be measured using the 7-item Partners at Care Transitions Measures. Scores will range from 7 to 30. Higher scores indicate greater care problems and more adverse events post discharge.

    Measured: Day 7 and 30

  18. Mortality Rate

    Count of days to date of patient death

    Measured: Day 60 and 180

  19. Montreal Cognitive Assessment 5-minute Protocol Score

    Cognitive function (attention, orientation, language, memory, and executive function) will be measured using the Montreal Cognitive Assessment 5-min protocol. Scores will range from 0 to 30. Higher scores indicate better cognitive function.

    Measured: Day 0, 60, and 180

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2026
  2. Study start22 Jul 2026
  3. Primary completionNov 2031 (estimated)
  4. Study completionNov 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
2,560 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07661355
Sponsor's protocol ID
IRB00145199
Other IDs
PLACER-2025C1-43844
Status last verified
May 2026
First submitted
16 Jun 2026
Last updated
21 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Patient-Centered Program and Family Caregiver Enhanced Program in people with Care Transition, run by Wake Forest University Health Sciences at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Michiyah Kimber (336-716-5719, michiyah.kimber@advocatehealth.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hospital-Free Days (time frame: Day 60). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in